-+ 0.00%
-+ 0.00%
-+ 0.00%

ACADIA Pharmaceuticals shareholders approved 5.21 million-share increase to 2024 equity plan

PUBT·05/29/2026 20:07:34
Listen to the news
ACADIA Pharmaceuticals shareholders approved 5.21 million-share increase to 2024 equity plan
  • ACADIA Pharmaceuticals held its annual shareholder meeting on May 29, 2026.
  • Shareholders adopted an amendment to the 2024 Equity Incentive Plan, authorizing 5,209,670 additional shares for issuance under the plan.
  • The plan amendment was approved; the filing does not state that any new awards or share issuances have been executed.
  • Shareholders ratified Ernst & Young as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ACADIA Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-248242), on May 29, 2026, and is solely responsible for the information contained therein.